Effect of Tetrabenazine on Stroop Interference in Huntington Disease
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Tetrabenazine (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 29 Mar 2018 Status changed from recruiting to completed.
- 23 Mar 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jan 2018 as per ClinicalTrials.gov record.
- 13 Apr 2015 Planned primary completion date changed from 1 Jan 2014 to 1 Jan 2016, according to to ClinicalTrials.gov record.